EA
ENZ

Emerald Acquisition’s Enzo Biochem, Inc. ENZ Stock Holding History

Emerald Acquisition’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$732K Buy
143,988
+48,039
+50% +$287K ﹤0.01% 2277
2016
Q2 		$573K Buy
+95,949
New +$532K ﹤0.01% 2413

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Emerald Acquisition's ENZ Position: Q3 2016 in Review

Emerald Acquisition increased its Enzo Biochem, Inc. (ENZ) stake by 50% in Q3 2016, buying an estimated $287K and bringing the position to 143,988 shares worth $732K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Emerald Acquisition first reported a position in ENZ in Q2 2016 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold ENZ as of Q3 2016.

  • Emerald Acquisition held 143,988 shares of Enzo Biochem, Inc. worth $732K as of Q3 2016.
  • Emerald Acquisition bought 48,039 Enzo Biochem, Inc. shares in Q3 2016, an estimated $287K.
  • Enzo Biochem, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2277 holding.
  • Emerald Acquisition first reported a position in Enzo Biochem, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.